A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Titel:
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Auteur:
Bowles, Daniel W. Kochenderfer, Mark Cohn, Allen Sideris, Lucas Nguyen, Nghia Cline-Burkhardt, Vivian Schnadig, Ian Choi, Minsig Nabell, Lisle Chaudhry, Arvind Ruxer, Robert Ucar, Antonio Hausman, Diana Walker, Luke Spira, Alexander Jimeno, Antonio